Skip to content
← Full study record

NCT00450450 · OUTCOME

Estimated Two-year Event-free Survival (EFS)

Donor Bone Marrow Transplant With or Without G-CSF in Treating Young Patients With Hematologic Cancer or Other Diseases · Source last updated 2022-04-28

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

Measure
NUMBER
Unit
Percentage of patients
Interval / dispersion
95% Confidence Interval
Time frame
at 2 years

What was measured

EFS is defined as relapse or treatment-related mortality (TRM). relapse is defined by either morphological or cytogenetic evidence of ALL consistent with pre-transplant features.

Analysis population: Early terminated study. One patient is inevaluable for EFS on experimental arm and is excluded from analysis.

Groups in this outcome

Control BM Arm

Conventional bone marrow transplant (BM)

Experimental G-BM Arm

G-CSF (filgrastim) stimulated bone marrow (G-BM)

Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.

Analysis denominator · Participants

GroupSource count
Control BM Arm13
Experimental G-BM Arm13

Reported measurements

Source class 1
Values in Percentage of patients · Interval/dispersion: 95% Confidence Interval
GroupValueSpreadLowerUpperComment
Control BM Arm66Not reported3286Not reported
Experimental G-BM Arm83Not reported4796Not reported
Complete source fields
classes
  1. categories
    1. measurements
      1. group Id
        OG000
        lower Limit
        32
        upper Limit
        86
        value
        66
      2. group Id
        OG001
        lower Limit
        47
        upper Limit
        96
        value
        83
denoms
  1. counts
    1. group Id
      OG000
      value
      13
    2. group Id
      OG001
      value
      13
    units
    Participants
description
EFS is defined as relapse or treatment-related mortality (TRM). relapse is defined by either morphological or cytogenetic evidence of ALL consistent with pre-transplant features.
dispersion Type
95% Confidence Interval
groups
  1. description
    Conventional bone marrow transplant (BM)
    id
    OG000
    title
    Control BM Arm
  2. description
    G-CSF (filgrastim) stimulated bone marrow (G-BM)
    id
    OG001
    title
    Experimental G-BM Arm
param Type
NUMBER
population Description
Early terminated study. One patient is inevaluable for EFS on experimental arm and is excluded from analysis.
reporting Status
POSTED
time Frame
at 2 years
title
Estimated Two-year Event-free Survival (EFS)
type
PRIMARY
unit Of Measure
Percentage of patients

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice